| Patent | Date |
|---|
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors
Grant 8,962,637 - Mc Allister , et al. February 24, 2 | 2015-02-24 |
Near full-genome assay of HCV drug resistance
Grant 8,911,934 - Vuagniaux , et al. December 16, 2 | 2014-12-16 |
Near Full-genome Assay Of Hcv Drug Resistance
App 20140187765 - Vuagniaux; Gregoire ; et al. | 2014-07-03 |
Pharmaceutical Compositions
App 20140005123 - Goncalves; Elisabete ; et al. | 2014-01-02 |
Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy
Grant 8,450,281 - Bernardi , et al. May 28, 2 | 2013-05-28 |
Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors
Grant 8,440,679 - Mc Allister , et al. May 14, 2 | 2013-05-14 |
Oxaliplatin active substance with a very low content of oxalic acid
Grant 8,211,940 - Ibrahim , et al. July 3, 2 | 2012-07-03 |
Oxaliplatin Active Substance With A Very Low Content Of Oxalic Acid
App 20100173988 - IBRAHIM; Houssam ; et al. | 2010-07-08 |
Cyclosporin with improved activity profile
Grant RE40,987 - Wenger , et al. November 17, 2 | 2009-11-17 |
Method Of Preparing Huperzine A And Derivatives Thereof
App 20090247754 - Underiner; Gail ; et al. | 2009-10-01 |
Use Of A Cyclic Undecapeptide For The Preparation Of A Medicament For Administration During Myocardial Ischaemic Events
App 20090023640 - Scalfaro; Pietro ; et al. | 2009-01-22 |
Device for packaging an oxaliplatin solution
App 20080108697 - Ibrahim; Houssam ; et al. | 2008-05-08 |
Pharmaceutically stable oxaliplatinum preparation for parenteral administration
Grant 7,070,796 - Ibrahim , et al. July 4, 2 | 2006-07-04 |
Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
Grant 7,012,072 - Ibrahim , et al. March 14, 2 | 2006-03-14 |
Cyclic undecapeptide pro-drugs and uses thereof
Grant 6,995,139 - Wenger , et al. February 7, 2 | 2006-02-07 |
Process for the purification of EPI-HNE proteins
Grant 6,989,438 - Poncin , et al. January 24, 2 | 2006-01-24 |
Cyclosporin with improved activity profile
Grant 6,927,208 - Wenger , et al. August 9, 2 | 2005-08-09 |
Oxalipatinum preparation packaging
Grant 6,866,857 - Mauvernay March 15, 2 | 2005-03-15 |
Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
Grant 6,814,982 - Poncin , et al. November 9, 2 | 2004-11-09 |
Cyclosporin derivatives and method for the production of said derivatives
Grant 6,790,935 - Mutter , et al. September 14, 2 | 2004-09-14 |
Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications
Grant 5,922,358 - Doutremepuich , et al. July 13, 1 | 1999-07-13 |
Pharmaceutically stable preparation of oxaliplatinum
Grant 5,716,988 - Ibrahim , et al. February 10, 1 | 1998-02-10 |
Biologically active drug polymer derivatives and method for preparing same
Grant 5,286,637 - Veronese , et al. February 15, 1 | 1994-02-15 |
Pharmaceutical composition in the form of microparticles
Grant 5,225,205 - Orsolini July 6, 1 | 1993-07-06 |
Sustained and controlled release of water insoluble polypeptides
Grant 5,192,741 - Orsolini , et al. March 9, 1 | 1993-03-09 |
Polyester-based composition for the controlled release of polypeptide medicinal substances
Grant 5,187,150 - Speiser , et al. February 16, 1 | 1993-02-16 |
Preparation containing hexatriacontapeptides and methods of use
Grant 4,839,343 - Waeber , et al. June 13, 1 | 1989-06-13 |
Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases
Grant 4,835,139 - Tice , et al. May 30, 1 | 1989-05-30 |
Microencapsulation by phase separation of water-soluble medicaments
Grant 4,673,595 - Orsolini , et al. June 16, 1 | 1987-06-16 |
| 